UBS analyst Joshua Spector raised the firm’s price target on Cabot (CBT) to $82 from $81 and keeps a Neutral rating on the shares.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CBT:
- Cabot to acquire Mexico Carbon Manufacturing from Bridgestone, terms undisclosed
- Cabot reports Q3 adjusted EPS $1.90, consensus $1.83
- Cabot backs FY25 adjusted EPS view $7.15 to $7.50, consensus $7.29
- CBT Earnings this Week: How Will it Perform?
- Cabot launches LITX 95F conductive carbon for energy storage systems